Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
The worldwide rise in obesity and diabetes has led to a massive spike in the number of people with non-alcoholic fatty liver disease, which often advances to a more severe condition known as non-alcoholic steatohepatitis, and in some cases to fibrosis and cirrhosis. This Outline discusses new ways to diagnose and treat this progressive condition.
Nature Outline: Fatty liver disease is an editorially independent supplement to Nature produced with the financial support from a third party. About this content.
Increased levels of obesity are driving an epidemic of non-alcoholic fatty liver disease. Understanding, diagnosing and treating this progressive condition are now priorities.